* Oct. 30, 10:30 a.m. — Jennifer Doudna, the 2020 Nobel laureate in chemistry, will speak about her work on CRISPR and its intersections with COVID-19 at the upcoming Distinguished Speaker Series in Research and Innovation. The free, online event, co-organized by the UC Davis Office of Research and the School of Medicine, will be live, but registration is required.
Doudna is a Howard Hughes Medical Institute investigator at UC Berkeley and founder of the Innovative Genomics Institute. She is also the Li Ka Shing Chancellor’s Chair and a professor in the departments of Chemistry, and Molecular and Cell Biology.
Doudna and Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology, won the Nobel Prize in chemistry Oct. 7 for their co-development of CRISPR-Cas9, a genome-editing tool that has revolutionized biomedicine and agriculture. Doudna and Charpentier are the first women to share a Nobel in the sciences.
Andy Fell, News and Media Relations, 530-752-4533, email@example.com
Nadine A. Yehya, UC Davis Health Public Affairs, 916-734-9040, firstname.lastname@example.org